Session Abstract – PMWC 2023 Silicon Valley

Showcase Track S1 - January 25 4.00 P.M.-4.30 P.M.,Showcase Track S1 - January 27 9.00 A.M.-9.45 A.M.

The PMWC 2023 Microbial Profiling Showcase will provide a 15-minute time slot for selected companies in the Microbiome and Pathogen ID fields. The human microbiome is composed of a wide variety of microorganisms that are essential for maintaining human health and preventing disease. Research in this area is accelerating due to the rapid development in genome sequencing technologies. This showcase will present some of the leading companies in microbial profiling and pathogen identification.

Confirmed Presenting Companies:

 Speaker Profile

Ph.D., CEO, EzBiome

Dr. Nur A Hasan is a molecular microbiologist with experiences in microbial genomics, microbiome, bioinformatics and molecular ecology. Dr. Hasan is an accomplished Executive with experience in strategic development of technology innovation in the biotechnology, pharmaceutical, and life science industries. In his multidisciplinary research experience, Dr. Hasan led numerous large-scale genomic, metagenomic and microbiome projects that resulted in multiple patents and over 100 peer-reviewed articles on microbiome, biomarker discovery, molecular ecology, and infectious diseases.

Microbial Profiling Showcase:

EzBiome is a microbiome company which applies precision microbiome discovery platform to shorten the time for discovery and development of microbiota-based therapeutics and companion diagnostics for microbiome-related diseases.

An Advanced Platform for Microbiome Biomarker Discovery
Empowering discovery of exciting new biology and microbiome biomarkers for companion diagnostics and therapeutics using precision taxonomy.

 Speaker Profile

Ph.D., Senior Bioinformatician, Diversigen

Wendy Phillips is a Senior Bioinformatician at Diversigen. She is a widely experienced computational and molecular biologist who has focused decades of research on inter-species interactions. At Diversigen, she leverages that experience to elucidate host-microbiome interactions using next generation sequence data and advanced computational analytics. Dr. Phillips holds a B.A. in Biological Sciences from The University of Chicago and a Ph.D. in Environmental Sciences from Oregon State University.

Microbial Profiling Showcase:

Diversigen empowers microbiome discovery through sequencing, analysis, and consulting services. The combined bench strength of Diversigen is unparalleled in the industry, providing you with access to those who are pioneering advancements in the microbiome field.

Multiomic visualization of the human gut microbiome
Optimized collection and multiomic analysis to visualize the impact of intermittent fasting on the gut microbiome.

 Speaker Profile

Ph.D., VP of Scientific Affairs and Partnerships, Clinical Microbiomics

Heidi Hau, PhD, leads business and scientific activities in the US including development strategies, external partnerships and CRO organization and execution. Previously, she’s led cross-functional R&D and translational biology programs across pharma, biotech startups and Fortune 500 companies. She’s worked across scientific and business development groups and directed global external innovation leading technical due diligence for external partnerships that focused on microbiological and molecular-based technologies. Most recently, she led key initiatives to expand investigational microbiota-based drug platforms for the treatment of infections and chronic diseases. As part of this role, she managed investigator-sponsored clinical studies and the led the Translational Biology team responsible for integration of microbiome basic research, discovery and clinical research enabling new or improved scientific understanding of microbiota-based therapeutics and/or assessment of new pipeline opportunities.

Microbial Profiling Showcase:
Clinical Microbiomics

Innovating at the forefront of microbiome science, we operate as an extension of our clients' research organizations. At Clinical Microbiomics, we work broader, analyze deeper, and connect the dots to help researchers find the answers they need to impact health and disease.

Strain tracking shows cross-generational engraftment after FMT
Engraftment analysis shows that strains are transferred from FMT donor to pregnant recipient and baby.